Univ Paris-Sud, UMR 8612, Châtenay Malabry, F-92296, France.
Int J Nanomedicine. 2011;6:2591-605. doi: 10.2147/IJN.S24552. Epub 2011 Oct 26.
Because of the described hazards related to inhalation of manufactured nanoparticles, we investigated the lung toxicity of biodegradable poly (lactide-co-glycolide) (PLGA) nanoparticles displaying various surface properties on human bronchial Calu-3 cells.
Positively and negatively charged as well as neutral nanoparticles were tailored by coating their surface with chitosan, Poloxamer, or poly (vinyl alcohol), respectively. Nanoparticles were characterized in terms of size, zeta potential, and surface chemical composition, confirming modifications provided by hydrophilic polymers.
Although nanoparticle internalization by lung cells was clearly demonstrated, the cytotoxicity of the nanoparticles was very limited, with an absence of inflammatory response, regardless of the surface properties of the PLGA nanoparticles.
These in vitro results highlight the safety of biodegradable PLGA nanoparticles in the bronchial epithelium and provide initial data on their potential effects and the risks associated with their use as nanomedicines.
由于吸入人工纳米粒子所带来的危害已被描述,我们研究了具有不同表面特性的可生物降解的聚(乳酸-共-乙醇酸)(PLGA)纳米粒子对人支气管 Calu-3 细胞的肺毒性。
通过分别用壳聚糖、泊洛沙姆或聚乙烯醇对正电荷、负电荷和中性纳米粒子进行表面包覆,从而对其进行定制。通过测量粒径、Zeta 电位和表面化学成分对纳米粒子进行了特性描述,证实了亲水聚合物提供的修饰作用。
尽管清楚地证明了肺细胞对纳米粒子的内化作用,但纳米粒子的细胞毒性非常有限,无论 PLGA 纳米粒子的表面性质如何,都没有炎症反应。
这些体外结果突出了可生物降解的 PLGA 纳米粒子在支气管上皮中的安全性,并提供了有关其作为纳米药物使用的潜在影响和相关风险的初步数据。